<DOC>
	<DOCNO>NCT00541788</DOCNO>
	<brief_summary>The purpose clinical phase I study measure efficacy side effect Common Sage treatment hot flash 10 patient prostate cancer receive androgen deprivation ( AD ) ( exclusively part multimodality treatment ) period minimum 6 month . Concomitant use non-steroidal anti-androgen first month AD permit prevent flair-up phenomenon . However , inclusion patient study start least 2 week cessation anti-androgen . This do exclude possible influence anti-androgen severity frequency hot flash . Once informed consent sign , patient receives study diary note daily frequency severity hot flash effect daily quality life . The severity hot flash measure Moyad score scale . The effect daily quality life measure use Hot Flash Related Daily Interference Scale ( HFRDIS ) . The patient instruct detail use diary . After week 1 , patient return diary responsible physician . In return patient receives study medication ( Common Sage , product ) diary next week ( =week 2 ) . This procedure repeat end observation period ( 2 month enrollment study ) . The common Sage provide tablet . The suggested dose Common Sage 3 tablet day ( morning - noon - evening ) . To sure effect Common Sage NOT due inhibition effect LHRH analogue , relate hormone ( testosterone , FSH , LH , free testosterone SHBG ) test three fixed moment : day study enrollment , 1 month study enrollment end study . In order check level hemoglobin cholesterol , every 2 week blood count perform . It show LHRH analogue induce anemia hypercholesterolemia . The investigator want measure possible effect Common Sage . There know side-effects use Common Sage . All symptom could relate use Common Sage record detail . Therefore , clinical examination include blood pressure registration perform responsible physician weekly base .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Common Sage Controlling Hot Flashes Prostate Cancer Patients Treated Androgen Deprivation</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Prostate cancer patient treat androgen deprivation experience hot flash . Karnofsky performance status ≥70 % Age ≥18 year Informed consent obtain , sign date specific protocol procedures Other therapy hot flash Mental condition render patient unable understand nature , scope , possible consequence study Patient unlikely comply protocol , i.e . uncooperative attitude , inability complete diary , inability return followup visit , unlikely complete study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>